Predictive value of NT-proBNP in vascular surgery patients with COPD and normal left ventricular systolic function

COPD: Journal of Chronic Obstructive Pulmonary Disease

Volumn 7, Issue 1, 2010, Pages 70-75

  Van Gestel, Yvette Rbm ^a   Goei, Dustin ^a   Hoeks, Sanne E ^a   Sin, Don D ^b   Flu, Willem Jan ^a   Stam, Henk ^a   Mertens, Frans W ^a   Bax, Jeroen J ^c   Van Domburg, Ron T ^a   Poldermans, Don ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Chronic obstructive pulmonary disease; N terminal pro B type natriuretic peptide; Vascular surgery

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE;

AGED; ARTERY RECONSTRUCTION; ARTICLE; CAROTID ENDARTERECTOMY; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DESCENDING AORTA SURGERY; DISEASE SEVERITY; FEMALE; HEART LEFT VENTRICLE CONTRACTION; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREDICTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SURGICAL PATIENT; VASCULAR SURGERY;

AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; COHORT STUDIES; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PREDICTIVE VALUE OF TESTS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SEVERITY OF ILLNESS INDEX; SURVIVAL ANALYSIS; VASCULAR SURGICAL PROCEDURES; VENTRICULAR FUNCTION, LEFT;

EID: 77949400522     PISSN: 15412555     EISSN: 15412563     Source Type: Journal    
DOI: 10.3109/15412550903499472     Document Type: Article

References (28)

1. Maisel AS, Krishnaswamy P, Nowak RM, et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med 2002; 347:161-167.
2. Lainchbury JG, Campbell E, Frampton CM, et al. Brain natriuretic peptide and n-terminal brain natriuretic peptide in the diagnosis of heart failure in patients with acute shortness of breath. J Am Coll Cardiol 2003; 42:728-735.
3. Berry C, Kingsmore D, Gibson S, et al. Predictive value of plasma brain natriuretic peptide for cardiac outcome after vascular surgery. Heart 2006; 92:401-402.
4. Schouten O, Hoeks SE, Goei D, et al. Plasma N-terminal pro-B-type natriuretic peptide as a predictor of perioperative and long-term outcome after vascular surgery. J Vasc Surg 2009; 49:435-441; discussion 441-1432
5. Le Jemtel TH, Padeletti M, Jelic S. Diagnostic and therapeutic challenges in patients with coexistent chronic obstructive pulmonary disease and chronic heart failure. J Am Coll Cardiol 2007; 49:171-180.
6. Ishii J, Nomura M, Ito M, et al. Plasma concentration of brain natriuretic peptide as a biochemical marker for the evaluation of right ventricular overload and mortality in chronic respiratory disease. Clin Chim Acta 2000; 301:19-30.
7. Lang CC, Coutie WJ, Struthers AD, et al. Elevated levels of brain natriuretic peptide in acute hypoxaemic chronic obstructive pulmonary disease. Clin Sci (Lond) 1992; 83:529-533.
8. Nagaya N, Nishikimi T, Okano Y, et al. Plasma brain natriuretic peptide levels increase in proportion to the extent of right ventricular dysfunction in pulmonary hypertension. J Am Coll Cardiol 1998; 31:202-208.
9. Bando M, Ishii Y, Sugiyama Y, et al. Elevated plasma brain natri-uretic peptide levels in chronic respiratory failure with cor pulmonale. Respir Med 1999; 93:507-514.
10. Bozkanat E, Tozkoparan E, Baysan O, et al. The significance of elevated brain natriuretic peptide levels in chronic obstructive pulmonary disease. J Int Med Res 2005; 33:537-544.
11. Stolz D, Breidthardt T, Christ-Crain M, et al. Use of B-type na-triuretic peptide in the risk stratification of acute exacerbations of COPD. Chest 2008; 133:1088-1094.
12. Schiller NB, Shah PM, Crawford M, et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiog-raphy. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocar-diograms. J Am Soc Echocardiogr 1989; 2:358-367.
13. Rabe KF, Hurd S, Anzueto A, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2007; 176:532-555.
14. Quanjer PH, Tammeling GJ, Cotes JE, et al. Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J Suppl 1993; 16:5-40.
15. Subbarao P, Lebecque P, Corey M, et al. Comparison of spirometric reference values. Pediatr Pulmonol 2004; 37:515-522.
16. Jelic S, Le Jemtel TH. Diagnostic usefulness of B-type natriuretic peptide and functional consequences of muscle alterations in COPD and chronic heart failure. Chest 2006; 130:1220-1230.
17. Lee TH, Marcantonio ER, Mangione CM, et al. Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery. Circulation 1999; 100:1043-1049.
18. Leuchte HH, Baumgartner RA, Nounou ME, et al. Brain natriuretic peptide is a prognostic parameter in chronic lung disease. Am J Respir Crit Care Med 2006; 173:744-750.
19. Rutten FH, Cramer MJ, Zuithoff NP, et al. Comparison of B-type natriuretic peptide assays for identifying heart failure in stable elderly patients with a clinical diagnosis of chronic obstructive pulmonary disease. Eur J Heart Fail 2007; 9:651-659.
20. Leuchte HH, Holzapfel M, Baumgartner RA, et al. Characterization of brain natriuretic peptide in long-term follow-up of pulmonary arterial hypertension. Chest 2005; 128:2368-2374.
21. Nootens M, Kaufmann E, Rector T, et al. Neurohormonal activation in patients with right ventricular failure from pulmonary hypertension: relation to hemodynamic variables and endothelin levels. J Am Coll Cardiol 1995; 26:1581-1585.
22. ten Wolde M, Tulevski, II, Mulder JW, et al. Brain natriuretic pep-tide as a predictor of adverse outcome in patients with pulmonary embolism. Circulation 2003; 107:2082-2084.
23. Tulevski, II, Groenink M, Van Der Wall EE, et al. Increased brain and atrial natriuretic peptides in patients with chronic right ventricular pressure overload: correlation between plasma neurohormones and right ventricular dysfunction. Heart 2001; 86:27-30.
24. Jourdain P, Jondeau G, Funck F, et al. Plasma brain natri-uretic peptide-guided therapy to improve outcome in heart failure: The STARS-BNP multicenter study. J Am Coll Cardiol 2007; 49:1733-1739.
25. Anand IS, Fisher LD, Chiang Y-T, et al. Changes in brain na-triuretic peptide and norepinephrine over time and mortality and morbidity in the Valsartan Heart Failure Trial (Val-HeFT). Circulation 2003; 107:1278-1283.
26. Tsutamoto T, Wada A, Maeda K, et al. Effect of spironolactone on plasma brain natriuretic peptide and left ventricular remodeling in patients with congestive heart failure. J Am Coll Cardiol 2001; 37:1228-1233.
27. Olsson LG, Swedberg K, Cleland JGF, et al. Prognostic importance of plasma NT-pro BNP in chronic heart failure in patients treated with a [beta]-blocker: Results from the Carvedilol Or Meto-prolol European Trial (COMET) trial. Eur J Heart Fail 2007; 9:795-801.
28. Sin DD, Wong E, Mayers I, et al. Effects of nocturnal noninva-sive mechanical ventilation on heart rate variability of patients with advanced COPD. Chest 2007; 131:156-163.